GRPR contributes to tumor growth and progression and is overexpressed in various cancers, including prostate, breast, small cell lung (SCLC), colon, gastrointestinal, and pancreatic cancer, as well as glioblastomas and neuroblastomas [150]. This evidence concerns the gene GRPR and cancer.